Sergey Jakimov is the co-founder and managing partner of LongeVC, an early-stage venture capital firm supporting innovative biotech and longevity. LongeVC has invested in startups across personalized medicine, cell rejuvenation, diagnostics, and more. A proud serial entrepreneur, Sergey is also the founder of several successful companies in biotech and engineering.
Sergey can discuss and provide expert commentary on the following topics:
Trends in cutting-edge biotechnology and longevity science.
How current market conditions impact investments in health tech and what this means for our health.
LongeVC's recent deals include AI-powered technology for personalized cancer treatments and liquid biopsies for life-saving early ovarian cancer detection.
The synergies between med tech and emerging technologies like AI, genomics, blockchain, and more.